Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores.
about
Advances in PEGylation of important biotech molecules: delivery aspectsGadolinium MRI contrast agents based on triazine dendrimers: relaxivity and in vivo pharmacokinetics.Porous Polymersomes with Encapsulated Gd-labeled Dendrimers as Highly Efficient MRI Contrast Agents.Macromolecular Imaging Agents Containing Lanthanides: Can Conceptual Promise Lead to Clinical Potential?Water-soluble Semiconducting Nanoparticles for Imaging.Dendrimeric β-cyclodextrin/Gd(III) chelate supramolecular host-guest adducts as high-relaxivity MRI probes.pH imaging of mouse kidneys in vivo using a frequency-dependent paraCEST agent.Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiographyMacromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.Controlled supramolecular oligomerization of C3-symmetrical molecules in water: the impact of hydrophobic shielding.Targeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, "one pot" synthetic approachMacromolecular and dendrimer-based magnetic resonance contrast agents.Prolonged blood circulation and enhanced tumor accumulation of folate-targeted dendrimer-polymer hybrid nanoparticlesBiodistribution of antibody-targeted and non-targeted iron oxide nanoparticles in a breast cancer mouse model.Paramagnetic liposomes for molecular MRI and MRI-guided drug delivery.Preparation, characterization and in vivo assessment of Gd-albumin and Gd-dendrimer conjugates as intravascular contrast-enhancing agents for MRI.MR lymphangiography with intradermal gadofosveset and human serum albumin in mice and primates.Nanoparticles for biomedical imagingBiologically optimized nanosized molecules and particles: more than just size.Preparation of cystamine core dendrimer and antibody-dendrimer conjugates for MRI angiographyICP-MS analysis of lanthanide-doped nanoparticles as a non-radiative, multiplex approach to quantify biodistribution and blood clearance.Strategies for the preparation of bifunctional gadolinium(III) chelators.Preparation and long-term biodistribution studies of a PAMAM dendrimer G5-Gd-BnDOTA conjugate for lymphatic imaging.The degradation and clearance of Poly(N-hydroxypropyl-L-glutamine)-DTPA-Gd as a blood pool MRI contrast agent.Recommendations for Benchmarking Preclinical Studies of NanomedicinesClearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signalsPharmacokinetics and magnetic resonance imaging of biodegradable macromolecular blood-pool contrast agent PG-Gd in non-human primates: a pilot study.An extracellular MRI polymeric contrast agent that degrades at physiological pHDendrimer-based contrast agents for molecular imagingIn vivo molecular imaging using nanomaterials: general in vivo characteristics of nano-sized reagents and applications for cancer diagnosis.Biodegradable polydisulfide dendrimer nanoclusters as MRI contrast agents.HER2/NEU GENE EXPRESSION PRODUCTS EVALUATED WITH SUPERPARAMAGNETIC, GENETICALLY ENGINEERED ANTIBODIESA dual CT-MR dendrimer contrast agent as a surrogate marker for convection-enhanced delivery of intracerebral macromolecular therapeutic agentsCellular magnetic resonance imaging: current status and future prospects.Dendrimer-Based Responsive MRI Contrast Agents (G1-G4) for Biosensor Imaging of Redundant Deviation in Shifts (BIRDS).PAMAM dendrimers as nano carriers to investigate inflammatory responses induced by pulmonary exposure of PCB metabolites in Sprague-Dawley ratsGadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: status and clinical potential.Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitroNanosystems for simultaneous imaging and drug delivery to T cells
P2860
Q28277255-A9A1FE15-BD42-4C5B-8562-8F90C5D20689Q30571992-5C1CFEF0-BB34-46FD-AF69-6E9CBE9C18DAQ30584790-8CA74A1A-52CC-40E2-B932-8505C73078F6Q30596925-268F07A3-1E79-4F93-ACC6-4567F9EBF7F9Q30754990-6EFD08E7-80E8-4D9D-B334-7B94291DEA53Q30820441-D57E8F79-D96F-40D3-905F-30616C069D63Q30980317-B1A899D2-DBBE-439C-BA44-1FB3ABC05CD3Q33570993-637DE4FE-1CCB-474F-ADE8-3EBBEC2985C1Q33847006-AEF41CF9-865D-47E9-9587-3A795CA19792Q33854266-CB67F27E-4943-48D3-A7EA-75FCF8E55654Q33941281-63D14F60-D55C-4CCD-8FA8-9A173D61B780Q34069230-E99878A7-DA19-4C21-9F15-4A2F6E87FFF1Q34145405-7D81F3A8-D90D-427D-8976-18430EAC902FQ34295949-8E366FC2-1945-4ACD-B965-6C42C3E0B60AQ34736942-D4E79B29-6365-427E-9312-E018B97776A5Q34850437-E908675F-4EDC-4CFD-9B51-F6A372D735C6Q34916107-3F02B80B-40EB-41CE-81B3-F513D0E8CE9DQ34989401-B97ECB90-E7F4-4255-AF86-0DC39496A39FQ35048175-15C793D6-1064-4282-9D29-688FAE8B785EQ35605967-C0AC364B-FCAF-4A19-9A18-081CCF2DDEC3Q35612858-CCF88027-67E2-4017-9455-2BFE6A7FCBB6Q35777941-0B925FB3-11DE-433A-BCB3-AF415D97C96CQ35786690-D35E8A62-90C6-48CF-8D2E-43F736EA76D2Q35973677-9BE252D2-40E4-4A4D-B9E6-E045279528B3Q36118071-A3360BBE-95F9-4040-A57B-154C587DD5E7Q36125194-43436077-0EF2-4D29-BCCA-FDBC4A6C8A77Q36158324-95F41401-B4AD-46E2-A264-314B4005D8EEQ36214917-5F46EAD1-D3A5-40E1-8849-59A1B67C8818Q36236679-69E741BD-E9F3-488B-AB5D-3D7F600B2BC2Q36266777-ED0FFAFB-9353-4A1B-85B9-F34CF439C8E5Q36373902-C484EAE0-1E6B-45C7-BBFD-1E757991405DQ36429106-D03584A0-6BEB-401C-8611-49FDFEF4EEC0Q36505059-062222E3-34C3-4254-91BA-2E60A8804DF2Q36516259-5B84FCD8-4192-47EC-9340-AF5681B190A9Q36546298-329A99F6-1D4E-4FDD-BECE-5B2842CDF06BQ36669347-5841149C-787F-4AF7-AB72-FA9D49C77640Q36717390-E7B316A9-1EC5-4E59-9FB0-D343C8A432F5Q36750157-04EFD1B7-EF19-4262-BE70-2FDCD7F7FF8CQ36760929-71541756-8B5D-44DA-9090-3F6CA8C97D99Q36871937-02329ED8-55E2-4005-BFA3-F30085AE1062
P2860
Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Macromolecular MRI contrast ag ...... ences between sizes and cores.
@en
Macromolecular MRI contrast ag ...... ences between sizes and cores.
@nl
type
label
Macromolecular MRI contrast ag ...... ences between sizes and cores.
@en
Macromolecular MRI contrast ag ...... ences between sizes and cores.
@nl
prefLabel
Macromolecular MRI contrast ag ...... ences between sizes and cores.
@en
Macromolecular MRI contrast ag ...... ences between sizes and cores.
@nl
P2093
P356
P1476
Macromolecular MRI contrast ag ...... ences between sizes and cores.
@en
P2093
Henry L Bryant
Hisataka Kobayashi
Martin W Brechbiel
Robert A Star
Sang-Kyung Jo
Satomi Kawamoto
P304
P356
10.1021/BC025633C
P577
2003-03-01T00:00:00Z